Concepedia

Margaret van Heek

MV

42

Publications

3.8K

Citations

25

H-Index

1988

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

AGCO (United Kingdom)

Cornell University

Margaret van Heek is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and physiology.

Top concepts

Publications per year

1988–2019

42

Publications

42

Diet-induced obese mice develop peripheral, but not central, resistance to leptin.

Margaret van Heek, Douglas S. Compton, C F France et al. · Journal of Clinical Investigation · 1997 · 746 citations · Full text

, , +18

Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy

Robert W. Myers, Hong-Ping Guan, Juliann Ehrhart et al. · Science · 2017 · 329 citations

, , +23

Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663

Margaret van Heek, Constance Farley, Douglas S. Compton et al. · British Journal of Pharmacology · 2000 · 327 citations · Full text

In Vivo Metabolism-Based Discovery of a Potent Cholesterol Absorption Inhibitor, SCH58235, in the Rat and Rhesus Monkey through the Identification of the Active Metabolites of SCH48461

Margaret van Heek, Constance F. France, Douglas S. Compton et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 305 citations

Fat Intake Affects Adiposity, Comorbidity Factors, and Energy Metabolism of Sprague‐Dawley Rats

Lorraine Ghibaudi, John A. Cook, Constance Farley et al. · Obesity Research · 2002 · 218 citations · Full text

Rows per page

1–5 of 42